| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ee602c630e57f59c6cfc1c1634e36064 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-32 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0492
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0456
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0476 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-32 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-20 |
| filingDate |
2019-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2021-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0420c764aef91c23c64a8f2e23f8807
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e367a893f45cb1acb52fcef358d8d48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0c8a5573d02f5abc6450673a03cf855
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d23be7f5a3dbd6c42aea2e34b51713e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c669db561c1c744a1ea5fc6db7606cd5 |
| publicationDate |
2021-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2019240656-B2 |
| titleOfInvention |
Systems and methods for transcutaneous direct current block to alter nerve conduction |
| abstract |
The present invention relates generally to attenuating or blocking nerve conduction. The systems and nmethods described herein can be used to alter the uninhibited nerve conduction that causes bladder ndysfunction, autonomic dysfunction, pain, and/or spasmodic muscle contractions in a patient affected nwith a neurological disorder. More specifically, the present invention relates to systems and methods nfor transcutaneous application of direct current (DC) to attenuate or block nerve conduction. The DC ncan be applied transcutaneously between at least two surface electrodes geometrically configured on na patient's skin so as to direct the flow of the DC in a direction sufficient to attenuate or block the ntransmission of action potentials in a target nerve.nWO 2017/044542 PCT/US2016/050643 n1/12 nI-nCC 00 n1nCr nw nLLL no c nO LL nu.. nCOU w nw |
| priorityDate |
2015-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |